Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Our pricing system is unavailable. You are viewing list price.
Please call 1-800-766-7000 to place your order or try our site again later.

R&D Systems™ Recombinant Human LINGO-1 Protein CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Manufacturer:  R&D Systems™ 9737LG050

Catalog No. 97-37L-G050

This item is not returnable. View return policy



The Recombinant Human LINGO-1 Protein is derived from HEK293. The Recombinant Human LINGO-1 Protein has been validated for the following applications: Bioactivity.


Lyophilized from a 0.2μm filtered solution in PBS with Trehalose.
60 kDa
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
<0.10 EU per 1μg of the protein by the LAL method.
FLJ14594, LERN1, LERN1UNQ201, leucine rich repeat and Ig domain containing 1, leucine rich repeat neuronal 6A, Leucine-rich repeat and immunoglobilin domain-containing protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A, LINGO1, LRRN6A, LRRN6Aleucine-rich repeat neuronal 6A, MGC17422
12 months from date of receipt, ≤ -20° C as supplied. 2 weeks, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution.
Reconstitute at 1 mg/mL in PBS.
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit